Abstract
Introduction: Membranous glomerulopathy is one of the most common causes of nephrotic syndrome in adults, with particular prevalence in women. This condition is characterized by thickening of the glomerular basement membrane, resulting in significant proteinuria and other clinical complications. The disease may have primary etiologies, such as the presence of antibodies against the phospholipase A2 receptor, or secondary to conditions such as infections, neoplasias and autoimmune diseases. In women, the clinical repercussions of membranous glomerulopathy may be more complex, since the interaction between hormones and immunological factors may influence the course of the disease and the response to treatment. Methodology: The research was conducted using the PRISMA checklist, with data collection from articles published in the last 10 years in the PubMed, SciELO and Web of Science databases. Five descriptors were used: "membranous glomerulopathy", "nephrotic syndrome", "women", "treatment" and "clinical implications". Inclusion criteria consisted of studies that addressed membranous glomerulopathy specifically in women, articles that presented clinical data, and peer-reviewed studies. Exclusion criteria included publications not related to the female population, articles with insufficient data, and non-original reviews. Results: The review revealed that membranous glomerulopathy in women is associated with a higher incidence of complications, including venous thrombosis and arterial hypertension. Treatments ranged from immunosuppressive to targeted therapies, with varied results in terms of remission and adverse effects. The quality of life of patients was significantly affected by the disease, highlighting the need for multidisciplinary management. Conclusion: Membranous glomerulopathy in women presents unique characteristics and clinical challenges, which demand special attention in diagnosis and treatment. Understanding the clinical repercussions and personalizing therapeutic approaches are essential to improve the quality of life of patients affected by this complex condition.
References
Morales E, Alonso M, Gutiérrez E. Collapsing glomerulopathy: update. Med Clin (Barc). 2019 May 3;152(9):361-367. English, Spanish. doi: 10.1016/j.medcli.2018.10.021. Epub 2018 Dec 13. PMID: 30554809.
Said JC, Letelier LM, González A, Escobillana C, Pisano R. Glomerulopatia colapsante [Collapsing glomerulopathy]. Rev Med Chil. 2012 Oct;140(10):1342-6. Spanish. doi: 10.4067/S0034-98872012001000016. PMID: 23559294.
Vazquez Martul E. Anatomía patológica del trasplante renal [The pathology of renal transplants]. Rev Esp Patol. 2018 Apr-Jun;51(2):110-123. Spanish. doi: 10.1016/j.patol.2017.10.001. Epub 2017 Nov 28. PMID: 29602372.
Vazquez Martul E. Microangiopatía trombótica/síndrome hemolítico urémico. Actualización de sus características histopatológicas [Thrombotic microangiopathy/haemolytic uraemic syndrome. Histopathology update]. Rev Esp Patol. 2018 Jul-Sep;51(3):170-177. Spanish. doi: 10.1016/j.patol.2017.10.007. Epub 2017 Dec 16. PMID: 30012310.
Lagranha CJ, Fiorino P, Casarini DE, Schaan BD, Irigoyen MC. Bases moleculares da glomerulopatia diabética [Molecular bases of diabetic nephropathy]. Arq Bras Endocrinol Metabol. 2007 Aug;51(6):901-12. Portuguese. doi: 10.1590/s0004-27302007000600003. PMID: 17934656.
de Lorenzo A, Tallón S, Hernández-Sevillano B, de Arriba G. C3 glomerulopathy: A new complement-based entity. Rev Clin Esp (Barc). 2014 Jun-Jul;214(5):266-74. English, Spanish. doi: 10.1016/j.rce.2014.01.016. Epub 2014 Feb 24. PMID: 24576419.
Corvillo F, López-Trascasa M. Acquired partial lipodystrophy and C3 glomerulopathy: Dysregulation of the complement system as a common pathogenic mechanism. Nefrologia (Engl Ed). 2018 May-Jun;38(3):258-266. English, Spanish. doi: 10.1016/j.nefro.2017.10.002. Epub 2017 Dec 24. PMID: 29279276.
Ruiz S, Soto S, Rodado R, Alcaraz F, López Guillén E. Peritonitis bacteriana espontánea como forma de presentación de síndrome nefrótico idiopático en un adulto de raza negra [Spontaneous bacterial peritonitis as form of presentation of idiophatic nephrotic syndrome in a black adult]. An Med Interna. 2007 Sep;24(9):442-4. Spanish. doi: 10.4321/s0212-71992007000900008. PMID: 18198954.
Pau Parra A, Ramos N, Perurena-Prieto J, Manrique-Rodríguez S, Climente M, García Quintanilla L, Escolano Á, Miarons M; en nombre del grupo PK-ECU-ORPHAR. Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy. Farm Hosp. 2024 Jan-Feb;48(1):16-22. English, Spanish. doi: 10.1016/j.farma.2023.07.009. Epub 2023 Aug 22. PMID: 37612186.
Santos FR. Glomerulopatia membranosa: novos conhecimentos na fisiopatologia e possibilidades terapeuticas [Membranous glomerulonephritis: new insights in pathophysiology and therapeutic approach]. J Bras Nefrol. 2014 Jan-Mar;36(1):59-62. Portuguese. doi: 10.5935/0101-2800.20140011. PMID: 24676616.
Hernández García E, Borrego García E, Navas-Parejo Casado A. Development of C3 glomerulopathy in a patient with acquired partial lipodistrophy. Nefrologia (Engl Ed). 2020 Jul-Aug;40(4):486-487. English, Spanish. doi: 10.1016/j.nefro.2019.08.002. Epub 2019 Dec 6. PMID: 31813591.
Gupta N, Wakefield DN, Clapp WL, Garin EH. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis. Nefrologia. 2017 Jan-Feb;37(1):78-86. English, Spanish. doi: 10.1016/j.nefro.2016.05.011. Epub 2016 Aug 29. PMID: 27595516.
Nadal MA, Monserrat AJ, Gotlieb D, López Blanco OA, Iotti R, Boschi A. Enfermedad de Gaucher y glomerulopatía con síndrome nefrótico [Gaucher's disease and glomerulopathy with nephrotic syndrome]. Medicina (B Aires). 1981;41(2):209-13. Spanish. PMID: 7024716.
Bernasovská G, Demes M, Oksa A, Pavlovic M, Vahancík A, Nyitrayová O, Gomolcák P, Danis D. Kolagenofibrotická glomerulopatia--raritná glomerulonefritída [Collagenofibrotic glomerulopathy--rare glomerulonephritis]. Vnitr Lek. 2006 Dec;52(12):1200-4. Czech. PMID: 17299915.
Hevia P, Nazal V, Rosati MP, Quiroz L, Alarcón C, Márquez S, Cuevas K; En Representación de la Rama de Nefrología de la Sociedad Chilena de Pediatría. Síndrome nefrótico idiopático: recomendaciones de la Rama de Nefrología de la Sociedad Chilena de Pediatría. Parte 1 [Idiopathic Nephrotic Syndrome: recommendations of the Nephrology Branch of the Chilean Society of Pediatrics. Part One]. Rev Chil Pediatr. 2015 Jul-Aug;86(4):291-8. Spanish. doi: 10.1016/j.rchipe.2015.05.005. Epub 2015 Sep 9. PMID: 26362970.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 João Antônio Moreira França, Sabrina Rodrigues Guedes, Lívia de Oliveira Cardoso, Rodrigo Rodrigues Fernandes Duarte, Guilherme Augusto Santana Silva , Patrick Lacerda Ribeiro, Gabriela de Souza Martins, Thiago Arruda Prado Cavalcante, Thamires Bárbara Cardoso da Silva, Ricardo Campos de Figueiredo Gonçalves, Gabriela de Freitas Ribeiro, Vanny Keller Silva França, Rodolfo Gomes Mato